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Sponges have generated significant interest as a source of bioactive and elaborate
secondary metabolites that hold promise for the development of novel therapeutics for
the control of an array of human diseases. However, research and development of marine
natural products can often be hampered by the difficulty associated with obtaining a stable
and sustainable production source. Herein we report the first successful characterization
and utilization of the microbiome of a marine invertebrate to identify a sustainable
production source for an important natural product scaffold. Through molecular-microbial
community analysis, optimization of fermentation conditions and MALDI-MS imaging,
we provide the first report of a sponge-associated bacterium (Micromonospora sp.)
that produces the manzamine class of antimalarials from the Indo-Pacific sponge
Acanthostrongylophora ingens (Thiele, 1899) (Class Demospongiae, Order Haplosclerida,
Family Petrosiidae). These findings suggest that a general strategy of analysis of the
macroorganism’s microbiome could significantly transform the field of natural products
drug discovery by gaining access to not only novel drug leads, but the potential for
sustainable production sources and biosynthetic genes at the same time.
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INTRODUCTION
Over 60% of approved pharmaceuticals are either natural prod-
ucts, derived from natural products via semi-synthesis and syn-
thesis, or modeled after natural product prototypes (Cragg et al.,
1997; Cragg and Newman, 2013). Marine invertebrates have
introduced a wealth of complex secondary metabolites as poten-
tial drug leads; however, the sustainable supply of these marine
invertebrate metabolites for development and clinical use remains
a challenge. With the development of metagenomics techniques
it is possible to assess large amounts of genetic information
directly from environmental samples, and natural products drug
discovery has moved toward a new frontier in discovery and
development. Mining the genetic information associated with the
microbiome of macroorganisms has provided unique opportuni-
ties to interrogate the role of the host’s microbial community in
the production of secondary metabolites (Owen et al., 2013).
Although the oceans represent the largest biosphere on Earth
and contain extraordinary biological and chemical diversity for
the discovery of drug leads, the majority of the potential drug-
producing groups of marine organisms come from extremely
delicate ecosystems that are vulnerable to over-harvesting, pol-
lution and climate change (Hughes et al., 2005; Ibrahim et al.,
2013). Presented here is a minimally invasive technique for sus-
tainable natural products exploration involving a phylogenetic
analysis of the entire microbiome followed by culture approaches
to interrogate the most likely drug-producing organisms. The
approach presented here illustrates the use of exploration of the
phylogeny of the microbiome leading to the rational selection of
culture approaches including a focus on biomimetic approaches
to yield the biosynthesis and production of the active metabolites
from a host associated microbe. This approach offers opportu-
nities to address both the discovery of unique metabolites from
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silent genes as well as the possibility of a sustainable supply from
rare and fragile natural product producing groups and in both
cases is minimally invasive.
Marine invertebrates, in particular, are composed of diverse
microbiomes that are challenging to characterize and culture
because of their unique relationships developed between the host
and the environment (Taylor, 2007; Waters et al., 2010). Most of
these invertebrates have co-evolved with microbial assemblages
that have become highly specialized and, in many cases, obli-
gate hence the need for community analysis and biomimetics
to achieve successful microbial cultivation and metabolite pro-
duction (Ruby et al., 2004). The isolation of the same groups
of natural products from both macroorganisms and microor-
ganisms has led to the hypothesis that the true producers are
the microorganisms associated with the invertebrates; however,
it has been difficult to identify a producing microorganism that is
truly responsible for the biosynthesis of these complex secondary
metabolites found in the invertebrate (Piel, 2004). Sponges have
been equated to natural microbial fermenters of the ocean and
represent a unique opportunity for mining sustainable micro-
bial sources for marine natural products (Hentschel et al., 2006).
Exploring these unique environmental conditions gives us yet
another piece of the puzzle to develop efficient biomimetic con-
ditions for the cultivation of previously unculturable microbes or
the activation of silent genes in established cultures. The manza-
mine class of alkaloids is a prime example regarding the useful
drug potential of unique marine structural classes as well as
the challenges that arise in supply, optimization and preclinical
development of complex marine molecules.
The manzamine class of alkaloids offer some remarkable
opportunities based on both the chemistry and therapeutic
potential for this group of metabolites. Manzamine A was orig-
inally described as a possible cancer lead, but has shown signifi-
cant activity against the malaria parasite Plasmodium falciparum
including a 2–7 fold greater activity compared to artemisinin
in vitro and a single dose clearance of the parasite from the
host (Sakai et al., 1986; Peng, 2010). Mycobacterium tubercu-
losis and serine/threonine kinases, such as GSK3-β and CDK5,
are also inhibited by manzamine A or derivatives (Kasanah
and Hamann, 2004; Peng, 2010). Treatment with manzamine A
impedes metastasis in cancer cell lines and sensitizes them to
TNF-related apoptosis-inducing ligand (TRAIL)-induced apop-
tosis (Guzmán, 2011). Wright et al. filed a patent for manzamine
A showing that when added to a cancer treatment regimen
cancer cells became susceptible to other treatments, but more
importantly cell invasion and tumor metastasis were also inhib-
ited by the inclusion of manzamine A (Guzmán et al., 2014).
Manzamine A has also shown promise as a suppressor of hyper-
lipidemia and atherosclerosis in vivo (Eguchi et al., 2013). The
manzamine family now consists of more than 80 β-carboline-
containing manzamine and manzamine-related alkaloids isolated
across nine genera of marine sponges from distinct geographi-
cal areas (Radwan et al., 2012). This broad distribution across
distantly related sponges suggested the putative role of a microor-
ganism for actual biosynthesis of the manzamine alkaloids
(Faulkner, 2000; Hu et al., 2003) (Supplementary Figure 1 and
Tables 1, 2).
Although the manzamine alkaloids possess potent bioactiv-
ity, their medicinal potential is limited in part by a lack of
constant supply of manzamine as well as key precursors for
medicinal chemistry, optimization and preclinical development
(Rao et al., 2004). While there are several common sponges
that produce large yields of manzamine alkaloids, harvesting
of wild populations of marine invertebrates is neither practi-
cal, nor environmentally sustainable. The structural complexity
of manzamine and lack of a cost-effective synthesis is currently
challenging for both medicinal chemistry studies and drug pro-
duction of a potential antimalarial agent (Jakubec et al., 2012).
Community analysis and biomimetic fermentation approaches
hold significant promise for a solution to the supply chal-
lenges and the availability of a sustainable source for the chem-
ically complex precursors that are critical to future medicinal
chemistry studies.
MATERIALS AND METHODS
SAMPLE COLLECTION
Several different specimens of A. ingens were collected by SCUBA
diving in Manado Bay, Indonesia at depths between 6 and 33m.
Sponges were transferred directly to plastic bags containing sea-
water. Sponge tissue was stored frozen at −80◦C until used.
The sponge tissue was lyophilized prior to molecular manipula-
tion. Water samples were collected in sterile 20-liter containers
adjacent to the sponges sampled. Water samples (10 L) were
filtered through 0.22μm-pore-size Sterivex filters (Millipore).
Nucleic acids were extracted from bacteria retained in the filters
as described by Somerville et al. (1989).
TOTAL DNA EXTRACTION FROM A. INGENS
DNA was extracted from lyophilized sponge tissue using a bead-
beater method adapted from Pitcher et al. (1989) Dried tissue
(4 g) was ground with a mortar and pestle and resuspended in
16mL of TE buffer and 4mL of isoamyl alcohol. The solution was
transferred to a 50mL bead-beater chamber (Biospec Products,
Inc.). Zirconia/silica beads (0.1 and 1mm) were added to 1/4
volume of the chamber and homogenized 4 times in 1min via
the bead-beater. The solution was transferred to a 50mL tube,
10mL of guanidium thiocyanate buffer was added, mixed gently,
and transferred to ice. Ammonium acetate (10M) was added to
a 2.5M final concentration. Standard phenol/chloroform extrac-
tion and chloroform/isoamyl alcohol extraction were followed.
DNA was precipitated with cold isopropanol, cleaned with 70%
(vol/vol) ethanol, and resuspended in TE buffer (pH 8). DNA was
quantified using a UV/Vis spectrophotometer.
BACTERIAL CLONE LIBRARY OF A. INGENS
PCR was performed using 100 ng of DNA with universal 16S
rRNA gene primers 8-27f (Weisburg et al., 1991) and 1492r
(Reysenbach et al., 1992) using Hi-Fi Platinum® Taq (Invitrogen).
Cycling conditions were as follow: initial denaturation at 94◦C
for 5min, 20 cycles of 94◦C for 30 s, 48◦C for 2min, 72◦C for
1.5min, and a final extension of 5min at 72◦C in a PTC-200
MJ-research thermal cycler (Bio-Rad). PCR products were puri-
fied by electrophoresis in a 1% (wt/vol) agarose gel and bands
of approximately 1500 bp were excised and recovered using a
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gel extraction kit (Qiagen, Inc.). Purified PCR products were
cloned with a TOPO®-XL cloning kit (Invitrogen) according to
the manufacturer’s instructions. Sequence of clones (>500 bp)
were manually aligned with Phydit software (Chun, 1995). The
tree was generated by the neighbor-joining algorithm (Saitou and
Nei, 1987) implemented in Phydit. The robustness of inferred
tree topologies was evaluated after 1000 bootstrap resamplings of
the neighbor-joining data, and only values >50% were shown. A
similar approach was used to more deeply investigate the bacte-
rial community closely related to Micromonospora strain M42. In
this case, the PCR reaction was performed with a primer M42-
16S (5′-GACCGTGAAAACCTGGGGC-3′) derived from the 16S
rRNA gene sequence of Micromonospora sp. strain M42 together
with reverse primer 1492r.
DENATURING GRADIENT GEL ELECTROPHORESIS (DGGE) AND
FLUORESCENT IN SITU HYBRIDIZATION ANALYSIS (FISH)
DGGE analysis was performed to compare the bacterial commu-
nities associated with A. ingens to that in the surrounding seawa-
ter. The procedure followed was described previously (Enticknap
et al., 2006). The numbers of bacteria associated with A. ingens
that are closely related to Actinobacteria was determined by FISH
analysis following the method described by Enticknap et al.
(2006) using the probe HGC69a (Roller et al., 1994).
ISOLATION AND IDENTIFICATION OF SPONGE-ASSOCIATED BACTERIA
A sponge microbial extract was obtained by grinding 1 cm3 of
sponge tissue in sterile artificial seawater using a mortar and
pestle. The extract was plated in a serial dilution (100 to 10−4)
on three different media types and incubated at 30◦C for up
to 3 weeks. Marine Agar 2216 (Difco), a non-selective medium,
ISP2 (Difco) and starch casein agar, both improve the growth of
Actinobacteria and were supplemented with a final concentration
of nalidixic acid (10μg/ml), cycloheximide (10μg/ml), nystatin
(25μg/ml) and 2% (wt/vol) NaCl. One morphotype of each bac-
terial colony was selected and subcultured until pure. Isolates
were identified by 16S rRNA gene sequence analysis. Bacterial iso-
lates were grown at 30◦C in 50mL broth of the medium from
which they were originally isolated. After 5 days of growth, DNA
was extracted from cell pellets using the Ultra-Clean® Microbial
DNA Isolation kit (Mo Bio Laboratories Inc.). The 16S rRNA
gene fragments were amplified by PCR using Platinum® TaqDNA
polymerase High Fidelity, primers 8-27f (Weisburg et al., 1991),
1492r (Reysenbach et al., 1992) and sequenced. Phylogenetic
analysis of isolates sequence was carried out as described above.
MANZAMINE A IDENTIFICATION AND EXTRACTION FROM
MICROMONOSPORA SP. M42 AND PRODUCTION OPTIMIZATION
All sponge microbes were grown in 500mL of ISP2 media sup-
plemented with 2% NaCl and grown at 28◦C for 14 days with
aeration. At the end of the fermentation time period, the cul-
tures were extracted with ethyl acetate three times (v/v). Extracts
were then screened using silica gel TLC (mobile phase CHCl3:
MeOH 9:1) and detected with the alkaloid specific Draggendorf
stain using the sponge-isolated manzamine A and 8 hydroxy-
manzamine A as standards. The Micromonospora sp. strain M42
was the only strain to show production and was consequently
cultured again in shake flasks and a 20-liter fermenter in ISP2
liquid medium with vigorous aeration at 30◦C. The media was
partitioned three times with ethyl acetate, dried and subjected
to silica gel vacuum-liquid chromatography and eluted begin-
ning with hexane (100%), hexane–acetone (9:1, 3:1, 1:1), acetone
(100%), chloroform–methanol (1:1) and finally with methanol
(100%). Fraction 3, eluted with hexane–acetone (3:1), was sub-
jected to HPLC chromatography (Phenomenex Luna 5μM250 ×
10.0mm column, flow rate 3ml/min, λ 254, 360 nm) using a gra-
dient solvent system of acetonitrile and water both with 0.1% TFA
to obtain manzamine A. To optimize production several differ-
ent media and growth conditions were explored including ISP2
media (4 g yeast extract, 10 g malt extract, 4 g dextrose/L) with
2% NaCl, ISP2 media with 2% artificial ocean, ISP2 with no salts
added, YM media (3 g yeast extract, 3 g malt extract, 3 g dex-
trose, 5 g peptone/L) with 2% artificial ocean, M4 media (10 g
glucose, 2 g casamino acid, 2 g yeast extract, 2 g beef extract/L)
with 2% artificial ocean, ½ dilution of YM media, marine broth
2216 (Difco), and marine broth 2216 (Difco) supplemented with
2 g glucose/L.
PRECURSOR DIRECTED BIOSYNTHETIC EXPERIMENTS
Commercially available tryptamine and sponge isolated ircinal
A were fed to M42. A 1 L culture of M42 in ISP2 media sup-
plemented with 2% (wt/vol) NaCl was shaken at 28◦C and
150 rpm for two days followed by addition of tryptamine and
ircinal A (each 25mg) and then continued incubation for an
additional three days. Cells and supernatant were separated by
centrifugation. The supernatant was extracted with chloroform
and evaporated under vacuum. The crude extract was passed
though SPE C-8 column before analysis using HPLC, LC-TOF
and NMR. These experiments were repeated four times yielding
an average 5-fold increase in manzamine A production. The same
experiments were repeated to obtain 15N-labeled manzamine A
by substituting 15N-labeled tryptamine.
LC-TOF- MS AND NMR ANALYSIS
LC-MS analysis was carried out on a Bruker microTOF with elec-
trospray ionization. Solutions of standard manzamine A from
the sponge and manzamine A and B obtained from a microbial
source were prepared in methanol and subjected to LCMS using a
reverse-phase C8 column (Phenomenex, 5μ, 4.6 × 150mm) elut-
ing at 0.4mL/min flow rate with 20min linear gradient from 20
to 100% phase B. Phase A was water and phase B was acetonitrile.
The NMR of both the sponge and bacteria associated manzamine
A were obtained on a Bruker 400MHz NMR in CDCl3.
EA-IRMS FOR 15N-LABELED MANZAMINE A
Samples and references were weighed into tin capsules, sealed,
and loaded into an auto-sampler on a Europa Scientific elemen-
tal analyzer. They are dropped in sequence into a furnace held
at 1000◦C and combusted in the presence of oxygen. The tin
capsules flash combust, raising the temperature in the region of
the sample to ∼1700◦C. The combusted gases are swept in a
helium stream over combustion catalyst (Cr2O3), copper oxide
wires (to oxidize hydrocarbons), and silver wool to remove sul-
fur and halides. The resultant gases, N2, NOx, H2O, O2, and CO2
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FIGURE 1 | Confirmation of manzamine A production by
Micromonospora sp. M42. (A) Acanthostrongylophora ingens, a common
Indo-Pacific manzamine producing sponge with the image of a colony of
Micromonospora sp. strain M42 with orange mycelial growth and black
spores. (B) Structure of manzamine A. (C) 1H NMR analysis comparison of
sponge derived and bacterial derived manzamine A. (D) MALDI-MS imaging
of manzamine A production on ISP2 over 10 days. 1st column: manzamine A
standard control (10μg on ISP2 agar); 1st row: Producing M42 colonies; 2nd
row: MALDI-MS imaging for [M+H]+ (549m/z); 3rd row: MALDI-MS imaging
for the [M−OH]+ fragment (532m/z); 4th row: non-producing M42 which
sporulates faster; 5th row: MALDI-MS imaging for [M+H]+ (549m/z)
showing no detectable production of manzamine A. The extraction of
replicate colonies yielded a HRESIMS signal of [M+H]+ = 549.3607m/z
(mean error: −2.86 ppm for manzamine A). (E) Production curve of
manzamine A from liquid ISP2 culture based on LC-TOF-MS and growth
curve of the bacteria based on OD600 measurements.
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FIGURE 2 | Neighbor-joining phylogenetic tree based on 16S rRNA gene sequence analysis showing the bacterial diversity of
Acanthostrongylophora sp.
are swept through a reduction stage of pure copper wires held
at 600◦C. This removes any oxygen and converts NOx species to
N2. A magnesium perchlorate chemical trap is used to remove
water. Nitrogen and carbon dioxide are separated using a packed
column gas chromatograph held at a constant temperature of
65◦C. The resultant nitrogen peak enters the ion source of the
Europa Scientific 20–20 IRMS first, where it is ionized and accel-
erated. Nitrogen gas species of different mass are separated in
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a magnetic field then simultaneously measured using a Faraday
cup collector array to measure the isotopomers of N2 at m/z 28,
29, and 30. After a delay the carbon dioxide peak enters the ion
source and is ionized and accelerated. Carbon dioxide gas species
of different mass are separated in a magnetic field then simulta-
neously measured using a Faraday cup collector array to measure
the isotopomers of N2 at m/z 44, 45, and 46. Both references and
samples are converted to N2 and analyzed using this method.
The analysis proceeds in a batch process by which a reference
is analyzed followed by a number of samples and then another
reference.
MALDI-MS IMAGING EXPERIMENTS AND HRMS
To prepare colonies for MALDI-MS imaging, 9–15mL thick ISP2
plates with 2% artificial ocean were poured and allowed to set
overnight. 5μL of Micromonospora sp. M42 was plated in 6 dis-
tinct places on the plate. The bacterium was allowed to grow at
30◦C in an incubator for 0–10 days. The plates were removed
from the incubator, individual colonies and appropriate controls
were cut from the agar and placed on a Bruker™MTP 384 ground
steel plate using a spatula. This was done slow enough to avoid the
trapping of air bubbles underneath the media. Then sinapic acid
(Sigma Aldrich) was sprinkled on top of the culture using a 20μm
sieve (Hogentogler & Co.) Then the colonies were dried in a vac-
uum oven (VWR 1410) for 8 h at 38◦C. Then the sample plate was
inserted into Bruker™ Autoflex II mass spectrometer equipped
with Compass 1.1 software suite (consists of FlexImaging 3.0,
FlexControl 2.4, and FlexAnalysis 2.4). The samples were ana-
lyzed in linear positive mode, with 200μm intervals. The spectra
were collected in 360–1200m/z mass range at 200Hz laser fre-
quency. After data acquisition, the data were analyzed using the
FlexImaging software (Yang et al., 2009; Roland et al., 2011; Xu
et al., 2012).
The MALDI-MS imaging used for this analysis only provides a
low resolution mass image thus six colonies were grown for each
day tested above. One colony was used for MALDI-MS imag-
ing, and the remaining five colonies for each day through the
entire time course. The colonies were combined and extracted
with CHCl3 three times with 30min of sonication with each
extraction. The extract was then eluted through a silica gel flash
column with 100% hexane, 90% hexane:10% acetone, 75% hex-
ane:25% acetone and 100% acetone. The 75% hexane fraction
which is the correct polarity for manzamine A based on previ-
ous sponge extractions was then subjected to high-resolution MS
using a Bruker microTOF ESI.
RESULTS
ISOLATION AND IDENTIFICATION OF SPONGE-ASSOCIATED BACTERIA
PRODUCING MANZAMINE A
Herein we report the isolation of manzamine A from a
Micromonospora sp. M42 isolated from the Indonesian sponge
A. ingens (Figures 1A,B) using molecular-microbial commu-
nity analysis, targeted microbiology, and Matrix Assisted Laser
Desorption Ionization- Mass Spectrometry (MALDI-MS) imag-
ing experiments to identify and validate it as a producer of
the manzamine alkaloids. We began by investigating the entire
sponge-associated bacterial community using a 16S rRNA gene
sequence analysis of the sponge-associated bacterial commu-
nity on a library of 117 clones. This yielded three domi-
nating groups, deltaproteobacteria (30%, n = 36), chloroflexi
(19%, n = 23) and actinobacteria (16%, n = 19), the remainder
FIGURE 3 | Confirmation of unique bacterial presence in the sponge
tissue. (A) DGGE analysis of a PCR negative control (C), seawater (W), and
Acanthostrongylophora sp. (S). The increase in bands in the sponge sample
indicates a higher diversity in the sponge than in the surrounding water
column. (B) Epifluorescence micrograph section of Acanthostrongylophora
sp. mesohyl tissue visualized by FISH. The mesohyl region was hybridized
with Cy-3 labeled HGC69a probe. Numerous high GC bacteria (possibly
actinobacteria) were undetectable in the water column, but clearly visible in
the sponge. Visualization of actinobacteria within A. ingens tissue by FISH
using a high-GC probe specific for actinobacteria (Montalvo, 2005) revealed
distribution throughout the sponge. Clusters of 20–50 high-GC bacteria
were randomly distributed throughout the mesohyl.
FIGURE 4 | TLC of alkaloids produced by M42 in either ISP2 or YM
compared to media and manzamine A and 8 hydroxymanzamine A
standards obtained from the sponge.
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FIGURE 5 | Phylogenetic analysis based on 16S rRNA gene sequence of cultured bacteria isolated from sponge Acanthostrongylophora sp. noted
in bold. The red box indicates the location of the manzamine A producing strain.
FIGURE 6 | Mass spectra of manzamine A standard vs. sinapic acid
matrix on MALDI. There were challenges in choosing the appropriate
matrix for MALDI MS imaging. After attempting several different MALDI
matrixes, sinapic acid was chosen due to its ability to ionize manzamine A
well, but without any interfering peaks. The fragment at 467m/z was not
used for imaging due to its low intensity and overlap with the matrix peaks.
of the community includes acidobacteria, gammaproteobacte-
ria, alphaproteobacteria, spirochaetes, and cytophaga-flexibacter-
bacteroides (CFB) related bacteria (Figure 2). As is commonly
found in bacterial community analysis of sponge-associated bac-
teria, in many cases the closest relatives of clones derived from
A. ingens were uncultured bacteria and bacteria found in com-
munity analysis of other sponge samples.
DGGE comparison of the sponge bacterial community to
the surrounding water column (Figure 3) showed it to be
both distinct and more diverse. Isolation of the heterotrophic
bacteria yielded eleven pure cultures: one gammaproteobacte-
ria (M37), two alphaproteobacteria (M31, M36), five firmi-
cutes (M28, M29, M39, M34, M40) and three actinomycetes
(M41, M42, M62). Marine agar 2216 yielded eight isolates
(M28, M29, M31, M34, M36, M37, M39, M40), starch casein
one isolate (M41) and ISP2 two isolates (M42, M62). Each
A. ingens isolate was tested for the presence of manzamines by
TLC (Figure 4). LC-TOF-MS analysis quickly identified a sin-
gle bacterial strain (M42) producing a compound with iden-
tical retention time and mass as manzamine A. This strain
was identified as a Micromonospora sp., closely related to
Micromonospora chalcea (X92594) through phylogenetic analysis,
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FIGURE 7 | HRESIMS from extracts of solid phase growth of M42 on ISP2.
and thus named Micromonospora sp. M42 (Figure 5). In order
to further investigate the presence of bacteria closely related to
Micromonospora sp. M42 in the sponge, a nested PCR approach
was used. Hundreds of colonies of which 96 were picked and
50 were sequenced. The phylogenetic analysis revealed that
this clone library comprised a majority of Micromonosporaceae
(60%) and also contained gamma-, delta-proteobacteria and
Acidobacteria.
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OPTIMIZATION OF CULTURE METHODS FORMICROMONOSPORA SP.
M42 TO PRODUCE MANZAMINE A
After exhaustive fermentation and isolation studies of M42, it
yielded a pure compound with the correlating mass and 1H NMR
of the sponge derived manzamine A (Figure 1C). To optimize
production several different media and growth conditions were
explored including ISP2 media with NaCl, ISP2 media with arti-
ficial ocean, ISP2 with no salts added, YM media with artificial
ocean, M4 media with artificial ocean, ½ dilution of YM media,
marine broth 2216, and marine broth 2216 supplemented with
glucose. Other growing conditions such as submerged fermenta-
tion, solid state fermentation, fermentation with various resins
(XAD2, XAD7, XAD 1180 and HP20) and fermentation with
extracted sponge fiber were also explored to optimize yield. The
hypothesis behind the use of the different resins and extracted
sponge fiber was that they would simulate the action of the sponge
by sequestering manzamine A from the culture thus eliminat-
ing any feedback mechanism to limit production. The highest
yield achieved was several mg/L in ISP2 liquid media grown for
7 days at 28◦C and 150 rpm and the whole culture extracted twice
with chloroform via liquid-liquid partition. However, the most
reproducible production yield of manzamine A was closer to and
frequently less than 1mg/L utilizing the same conditions.
CONFIRMATION OF MANZAMINE A PRODUCTION
To further verify the production of manzamine A, MALDI-MS
imaging was performed (Figure 1D). After many experiments,
sinapic acid was the matrix that gave the best ionization with
FIGURE 8 | Feeding ircinal and tryptamine results in an increase in
manzamine A production. The error bars represent the range of the
positive and negative standard deviation.
the least interference (Figure 6). Manzamine A production over
16 days in liquid culture revealed that manzamine A is initially
produced in a linear fashion and then metabolized by the organ-
isms resulting in undetectable levels of manzamine A after day
10 (Figure 1E). The MALDI-MS imaging results qualitatively
show the same production pattern over a 10 day time course.
Production of manzamine A is not detectable until day 4, peaks
around day 6 and then is excreted and eventually metabolized by
day 10. The two main signals seen in the manzamine A standard
are 549 and 532m/z. These same masses are observed being pro-
duced in the colonies in overlapping areas starting at day 5. The
MALDI-MS imaging used for this analysis is only low resolution
mass, thus additional colonies were cultured, extracted, purified
and subjected to HRMS analysis. This yielded a HRMS for the
microbial extract with a signal at 549.3607m/z which corresponds
to the [M+H]+ of manzamine A (mean error: −2.86 ppm).
The standard sponge isolated manzamine A was measured after
this microbial product and showed a signal at 549.3638m/z
which corresponds to the [M+H]+ of manzamine A (mean
error: −8.06 ppm) (Figure 7). Thus, providing further evidence
that the low resolution signal seen in the MALDI-MS imaging is
manzamine A.
Further support of the biogenesis of manzamine A byM42 was
obtained through preliminary biosynthetic studies. Tryptamine
and ircinal A were added to M42 cultures in ISP2 media and this
resulted in an approximate 5-fold increase in manzamine A pro-
duction demonstrating the potential ability of M42 to convert
precursors to manzamine A (Figure 8). This same increase could
not be seen when tryptophan replaced the tryptamine in cul-
ture. As a control experiment, perillaldehyde and tryptamine were
added to the culture to see if the Pictet-Spengler reaction would
occur with a similar aldehyde. This experiment yielded none of
the expected products.
Several attempts have been made to insert a labeled atom into
the production media of M42 in order to obtain a labeled manza-
mine A molecule. All attempts at producing manzamine A from
the bacteria in minimal media failed. Manzamine A could only
be obtained under rich media conditions and any dilution of
these media results in drastic reduction or elimination of man-
zamine A production. Therefore, attempts were made to insert a
label into the rich media utilizing [U-13C] glucose. While studies
showed that the bacteria produced manzamine A in the presence
of [U-13C] glucose, no incorporation could be detected by MS or
NMR due to the low incorporation of labeled isotope. In addi-
tion to the labeled glucose several forms of labeled acetate were
also tested (CD3COONa, CH3COO15NH4, and 13CH133 COONa)
and gave similar production of manzamine A, but not detectable
incorporation by MS or NMR. These results are not unexpected
due to the richness of the media and other starting materials
Table 1 | Analysis of 15N Incorporation by EA-IRMS of 15N-labeled tryptamine by M42 to produce 15N labeled manzamine A (MA).
Sample Mean d13CV-PDB () SD () Mean d15NAir () SD () Mean 15N/14N SD
M42 MA −22.20 0.10 4.21 0.22 0.003692 0.000001
15N M42 MA −21.99 0.02 1424 125 0.0089 0.0005
Sponge MA −22.54 0.05 4.26 0.16 0.003692 0.000001
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FIGURE 9 | Potential routes for A. ingens derived metabolites.
Biotransformation results using manzamine standards are displayed as well as
plausible explanation for related metabolites. Microorganisms: (1) Fusarium
solani F0007, (2) Micromonospora M42, (3) Fusarium oxysporium f.sp. gladioli
ATCC 1113713, (4) Bacillus sp. VAN35 (M28), (5) Streptomyces seokies, (6)
Fusarium oxysporium ATCC 760114, (7) Nocardia sp. ATCC 2114514 were
capable of transforming MA into a related metabolite (Ref. = Peng, 2003,
Plausible biosynthetic route for manadomanzamines in this reference).
being available for the biosynthesis of manzamine A. Finally, 15N
labeled tryptamine was added to the culture in a similar fash-
ion to the precursor directed feeding experiments outlined above.
This yielded successful incorporation of 15N based on Elemental
Analysis Isotope Ratio Mass Spectrometry (EA-IRMS). Table 1
outlines the part per thousand and standard deviations for M42
produced manzamine A, sponge isolated manzamine A, and 15N
enriched manzamine A obtained from the above conditions. The
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FIGURE 10 | Inhibition of M42 growth by manzamine A. Increasing
manzamine A concentration inhibits the growth of M42 in a dose
dependent fashion. The error bars represent the range of the positive and
negative standard deviation.
data shows an increase in the presence of 15N compared to
the other unenriched samples. The 2.5 times incorporation of
15N was enough to be seen via EA-IRMS, but not less sensitive
techniques such as MS or NMR.
DISCUSSION
Through molecular-microbial community analysis, optimiza-
tion of fermentation conditions and MALDI-MS imaging, the
first report of a sponge-associated bacterium (Micromonospora
sp. M42) that produces the manzamine class of antimalarials
from the Indo-Pacific sponge A. ingens is presented. The 16S
rRNA gene sequence analysis of the sponge-associated bacterial
community yielded deltaproteobacteria, chloroflexi, actinobac-
teria, acidobacteria, gammaproteobacteria, alphaproteobacteria,
spirochaetes and CFB related bacteria (Figure 2). As seen in
previously reported sponge community analysis (Webster et al.,
2001), actinobacteria was one of the major components of the
bacterial community. Bacterial isolation efforts yielded ten pure
cultures only one of which, Micromonospora sp. M42, was shown
to produce manzamine A.
MALDI-MS imaging was chosen to confirm manzamine A
production because it gives the widest available mass range, as
well as having the best established techniques and protocols for
experimental development and design. The main benefit of this
analytical method is the ability to perform a time course experi-
ment and see the production of the metabolite in question being
produced and consumed in its native environment or under cul-
ture conditions. Since the first report of MALDI-MS imaging on
microorganisms was published in 2008, the technique has grown
in popularity and shown its diverse utility in discovery of new nat-
ural products; characterization of the ecological role via spatial
localization experiments within colonies; exploration of biosyn-
thetic origins of natural products andmetabolic profiles related to
phenotypic studies (Esquenazi et al., 2008, 2011; Simmons et al.,
2008; Taniguchi et al., 2009; Yang et al., 2009; Kersten et al., 2011;
Liu et al., 2011; Xu et al., 2012; Jaeger et al., 2013; Shih et al.,
2014). While MALDI-MS imaging has numerous benefits, it is
important to be aware of the challenges. The first of which is the
application of matrix to the sample in order for the ionization
process to occur. This was a particularly challenging aspect for
confirming manzamine A production. A matrix has to be identi-
fied that would allow manzamine A to ionize effectively, but not
produce interfering signals. For this reason both ISP2 and YM
media from above were analyzed with 4 different matrixes (2,5-
dihydoxybenzoic acid, sinapic acid, 2,5-dihydroxyacetophenone,
and α-cyano-4-hydroxycinnamic acid). As different experiments
show, the production of manzamine A has a finite window
for detection. Stability studies revealed that degradation of the
metabolite is not caused by solvent; however, we cannot rule out
external enzymatic degradation. Another limitation of MALDI-
MS imaging is that is can only produce qualitative results. This
is due to the inherently imprecise application of matrix leading
to appreciable pixel-to-pixel variability (Watrous and Dorrestein,
2011; Yang et al., 2012). To minimize these effects on the overall
qualitative analysis, all colonies (day 0–10) were run at the same
time using the same MALDI plate leading to only one uniform
application of matrix.
The microbial production appears to typically produce only
manzamine A and under specific conditions small amounts of
the 8-hydroxy manzamine A. Despite the fact that over 80 man-
zamine alkaloids are reported in the literature from sponges, it is
apparent that all could be formed by plausible biotransformation
mechanisms involving oxidations and rearrangement. Figure 9
provides an overview of the known and plausible biotransforma-
tion reactions leading to the manzamine alkaloids isolated from
sponges beginning with just manzamine A (Kasanah et al., 2003).
As with all natural products produced frommicrobial sources,
identifying and having the ability to manipulate the biosynthetic
pathway would help to solve the production and stability issues
plaguing the manzamine story. In the first biosynthetic scheme
proposed for manzamine A (Baldwin et al., 1996), a pyridinium
dimer undergoes a Diels-Alder reaction followed by hydrolysis to
generate an aldehyde similar to ircinal A. This aldehyde can react
with tryptamine through a Pictet-Spengler reaction, produc-
ing manzamine D in a similar biochemical mechanism as plant
strictosidine synthase (Maresh et al., 2008). Further oxidation
would yield the aromatic β-carboline ring system. The prelimi-
nary biosynthetic confirmation experiments presented here show
that M42 is capable of increasing the production of manzamine A
when proposed precursors (tryptamine and iricinal A) are added
to the culture. Using substrates with similar active functional
groups such as perillaldehyde instead of iricinal A did not yield
any of the expected Pictet-Spengler products. This further sup-
ports that the production is specific to the substrates and will not
work on just any aldehyde tryptamine combination.
Consistent and stable production of manzamine A by M42
has proven to be challenging. In subsequent fermentations over
the decade since M42 was originally isolated, a strain of M42
was identified that does not produce detectable levels of manza-
mine. However, when returning to the original 2002 M42 strain
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FIGURE 11 | Increased amplification of actinobacteria. Using a universal primer as well as an actinobacteria primer resulted in a higher amplification of
actinobacteria 16s RNA. This result is consistent with those published by Farris and Olson (2007).
for MALDI-MS imaging, production could again be detected.
Figure 1D shows the non-detectable production of manzamine
A in the later strains in contrast to the original glycerol stocks
of M42. It is clear from this image that the non-producing strain
sporolates at least 24 h before the original strain and never obtains
the deep orange color characteristic of M42. Partial 16S rRNA
gene sequences from both strains were amplified and sequenced
using the primers 27F 5′-AGAGTTTGATCMTGGCTCAG-3′ and
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1492R 5′-TACGGYTACCTTGTTACGACTT-3′ (Lane, 1991). The
sequence was deposited in Genbank under accession number
EF513641. The 16S rRNA analysis of these strains showed both
to be identical. Further genetic analysis in the differences of these
strains is ongoing and may shed light on the biosynthesis of the
manzamines. It is possible that the biosyntheticmachinery is plas-
mid derived and can be lost or acquired through horizontal gene
transfer. The wide distribution of manzamine alkaloids in dif-
ferent sponge species suggests that the machinery is able to be
acquired by multiple microorganisms, most suitably in plasmid
form. Other research suggests that secondary metabolite produc-
tion can decrease and even become non-existent after multiple
generations of subcultures as is the case with the camptothecins
(Kusari et al., 2009).
The symbiotic relationship between the invertebrate and the
bacteria has successfully evolved to yield g/L scale production in
the sponge vs. the less than mg/L scale by the microbe. We have
seen that manzamine A inhibits the growth of M42 at 12μg/mL;
much larger concentrations are found in the sponge, thus sup-
porting the proposed sequestration of large amounts of manza-
mine alkaloids in a manner that is not toxic to the bacterium
(Figure 10). These data indicate that M42 could provide chemical
defense for A. ingens in exchange for habitat or acting as a natural
continuous-flow bioreactor. A reasonable explanation for the data
presented is that manzamine A is produced at low levels by M42
within the sponge but accumulates over the lifetime of the organ-
ism to the concentrations seen in the field. A second possibility
is that M42 is present at a high population within the sponge;
however, this seems unlikely due to the lack of representation in
the 16S rRNA gene clone library from the sponge and detailed
FISH analysis. A third possibility is that M42 is not the only pro-
ducer but rather the only bacterium that has been cultivated.
To examine this hypothesis, a primer based on M42 16S rRNA
gene was designed and coupled to a eubacterial universal primer
1492r. Using a nested PCR approach, a clone library of 16S rRNA
genes enriched for those related toM42 were obtained. One clone,
OPM11 was closely related toMicromonospora spp. No sequences
matching exactly that of Micromonospora sp. strain M42 was
recovered. The analysis revealed several sequences closely related
to M42 that were not previously seen (Figure 11). The bacte-
rial community associated with A. ingens could be elucidated in
more detail by using next generation sequencing approaches and
bacterial species of interest could be better quantified by addi-
tional FISH analyses in future work. Yet another possibility is the
transfer of genes horizontally between unrelated bacteria, which
would produce multiple producers that would avoid detection by
homology based approaches. All of these are possible explana-
tions for the discrepancy in total yields between the laboratory
and the field.
With the use of community analysis studies, Micromonospora
sp. M42 is the first sponge associated actinomycete bacteria that
has been shown to produce a sponge derived metabolite (Hill
et al., 2005). A culturable producing strain provides opportuni-
ties for overcoming future supply challenges that hinder marine
natural products development into usable drugs; however, sig-
nificant improvements in culture and production methods will
need to be developed. Despite the successful production from
a single pure culture, it has become quite evident that signifi-
cant barriers in drug production and successful biomimetics for
culture conditions still remain. The cumulative data presented
confirms that M42 is capable of producing manzamine A, and
although the yields are not yet sufficient to provide a practical
solution for drug development, it provides an important starting
point for chemical biology, precursor directed feeding experi-
ments and improvements in gene expression to generate higher
producing strains. This study also illustrates the unique potential
for applying molecular phylogeny for the exploration of inverte-
brate microbiomes in the discovery and development of natural
products.
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